ABSTRACT
Sex differences in the psychological impact of the COVID-19 pandemic have been consistently reported, showing disproportionally high rates of anxiety/distress in women relative to men. The mechanisms underlying this sexual dimorphism remain unclear. The present study queries the potential protective role of early hyperandrogenism on brain development. A natural model of sex-steroids abnormality, classic congenital adrenal hyperplasia (CAH), was used to test this question. CAH is characterized by adrenal androgen overproduction in utero (prenatal) through the neonatal critical developmental period. An online survey collected information on subjective responses to the COVID-19 pandemic. Matched on demographic variables, 60 adults carrying a diagnosis of classic CAH and 240 adults from the general population (non-CAH) were compared on levels of anxiety/distress in the first year of the COVID-19 pandemic (May 2020-April 2021). Structural Equation Modeling was used to test the modulation by CAH status of Sex effects on anxiety/distress. Results revealed lower levels of anxiety/distress in the female CAH group compared to the other 3 groups (male CAH, female non-CAH, and male non-CAH). This finding suggests that pre-neonatal hyperandrogenism might impact the development of neural circuits underlying anxiety processes, in a way that enhances resilience to chronic stress.
Subject(s)
Adrenal Hyperplasia, Congenital , COVID-19 , Hyperandrogenism , Adult , Infant, Newborn , Pregnancy , Humans , Female , Male , Sex Characteristics , Pandemics , Hyperandrogenism/epidemiology , Hyperandrogenism/psychology , COVID-19/epidemiology , Adrenal Hyperplasia, Congenital/diagnosis , Adrenal Hyperplasia, Congenital/epidemiology , Adrenal Hyperplasia, Congenital/psychology , Anxiety/epidemiology , Gonadal Steroid Hormones , SteroidsABSTRACT
BACKGROUND: Depending on CYP21A2 genotype, congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency leads to biochemical alterations (including hyperandrogenism, hypocortisolism, and hypoaldosteronism) and a wide spectrum of phenotypic disease manifestation. The latter include life-threatening salt-wasting crises, prenatal virilization of genitalia in women (classic CAH [C-CAH]) as well as milder forms of the disease exclusively presenting with hirsutism, acne or reduced fertility (nonclassic CAH [NC-CAH]), and could influence sexual function and identity. AIM: The present study evaluated sexual function, gender identification, and partner preference in women with C-CAH and NC-CAH. METHODS: In a cross-sectional cohort analysis, 35 female patients with CAH were divided into 2 groups: C-CAH (salt-wasting/simple virilizing; n = 17) and NC-CAH (n = 18) according to genotype and phenotype. Sexual function and sexual distress were assessed using established questionnaires, including the Female Sexual Function Index. Phenotype (defined by signs of hyperandrogenism) was assessed clinically (Ferriman-Gallwey score) and with the ovulatory function index. CYP21A2 genotype was determined by Sanger sequencing and multiplex ligation-dependent probe amplification. Sexual function was also separately analyzed in the context of clinical signs of androgenization in women with (n = 13) and without acne (n = 22). OUTCOMES: The study outcomes were sexual function and sexual distress in relation to genotype, clinical signs of androgenization, and biochemical parameters. RESULTS: Women with NC-CAH had significantly lower orgasm scores, a trend toward lower sexual function with higher sexual distress, as well as biochemical evidence of hyperandrogenism (higher dehydroepiandrosterone sulfate and lower SHBG) and a trend toward more clinical signs of hyperandrogenism (hirsutism). Indicators of in utero and childhood androgen excess as well as the presence of acne in all patients were related to lower sexual function and higher sexual distress. Clinical signs of hyperandrogenism correlated well with cardiovascular and metabolic risk factors. CLINICAL TRANSLATION: Women with NC-CAH and women with clinical signs of hyperandrogenism demonstrated higher distress compared to women with C-CAH and women without clinical signs of hyperandrogenism, respectively, regarding different aspects of sexual function. CONCLUSIONS: These data underline the importance of early diagnosis and therapy initiation, especially in patients with NC-CAH. Schernthaner-Reiter MH, Baumgartner-Parzer S, Egarter HC, et al. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia. J Sex Med 2019;16:1529-1540.
Subject(s)
Adrenal Hyperplasia, Congenital/genetics , Marriage/psychology , Sexual Behavior/psychology , Adrenal Hyperplasia, Congenital/physiopathology , Adrenal Hyperplasia, Congenital/psychology , Adult , Cohort Studies , Cross-Sectional Studies , Dehydroepiandrosterone Sulfate/metabolism , Female , Gender Identity , Genotype , Humans , Hyperandrogenism/genetics , Hyperandrogenism/psychology , Orgasm/physiology , Phenotype , Steroid 21-Hydroxylase/geneticsABSTRACT
No disponible
Subject(s)
Humans , Female , Hyperandrogenism/therapy , Virilism/therapy , Practice Patterns, Physicians' , Risk Factors , Hyperandrogenism/psychology , Polycystic Ovary Syndrome/complications , Obesity/complications , Cushing Syndrome/complicationsABSTRACT
Context: Polycystic ovary syndrome (PCOS) is associated with increased psychological distress, obesity and hyperandrogenism being suggested as key promoters. Objectives: To investigate the prevalence of anxiety/depression and their coexistence in women with PCOS/PCOS-related symptoms at ages 31 and 46. The roles of obesity, hyperandrogenism, and awareness of PCOS on psychological distress were also assessed. Design: Population-based follow-up. Setting: Northern Finland Birth Cohort 1966 with 15-year follow-up. Participants: At age 31, a questionnaire-based screening for oligoamenorrhea (OA) and hirsutism (H): 2188 asymptomatic (controls), 331 OA, 323 H, and 125 OA plus H (PCOS). Follow-up at age 46: 1576 controls, 239 OA, 231 H, and 85 PCOS. Interventions: Questionnaire-based screening for anxiety and depression symptoms (Hopkins Symptom Checklist-25) and previously diagnosed/treated depression at ages 31 and 46. Body mass index (BMI), serum testosterone/free androgen index, and awareness of polycystic ovaries/PCOS on psychological distress were also assessed. Main Outcomes: Population-based prevalence of anxiety and/or depression in women with PCOS/PCOS-related symptoms at ages 31 and 46. Results: Anxiety and/or depression symptoms, their coexistence, and rate of depression were increased at ages 31 and 46 in women with PCOS or isolated H compared with controls. High BMI or hyperandrogenism did not associate with increased anxiety or depression symptoms. The awareness of PCOS was associated with increased anxiety. Conclusions: Women with PCOS or isolated H present more often with anxiety and/or depression symptoms and their coexistence compared with controls. High BMI or hyperandrogenism did not provoke psychological distress in PCOS. The awareness of PCOS increased anxiety but did not associate with severe anxiety or depression.
Subject(s)
Anxiety/epidemiology , Depression/epidemiology , Hirsutism/epidemiology , Hyperandrogenism/epidemiology , Obesity/epidemiology , Oligomenorrhea/epidemiology , Polycystic Ovary Syndrome/epidemiology , Stress, Psychological/epidemiology , Adult , Anxiety/psychology , Depression/psychology , Female , Finland/epidemiology , Hirsutism/psychology , Humans , Hyperandrogenism/psychology , Middle Aged , Obesity/psychology , Oligomenorrhea/psychology , Polycystic Ovary Syndrome/psychology , Premenopause , Prevalence , Stress, Psychological/psychology , Surveys and QuestionnairesABSTRACT
Both prenatal and circulating testosterone and other androgens have been suggested to influence the individual's propensity to commit crime, but empirical evidence is limited and inconsistent. Congenital Adrenal Hyperplasia (CAH) and Polycystic Ovary Syndrome (PCOS) are both hyperandrogenic conditions but with an important difference; whereas subjects with CAH are exposed to high concentrations of androgens in utero, women with PCOS are subjected to high androgens in adulthood. Comparing these groups can therefore yield important insights of androgenic effects on behavior. In the current study, information on medical diagnoses and convicted crimes were gathered from Swedish population-based registers. The associations between diagnoses of CAH or PCOS and any crime, violent crime or sex crime were estimated with conditional logistic regression. Results showed that CAH in women and men did not predict criminality, whereas an increased risk for any crime and violent crime was found in PCOS women. Our findings indicate that female hyperandrogenism in adulthood, but not prenatal hyperandrogenism, is associated with risk for criminal behavior. Further research into hyperandrogenic conditions holds opportunities to deepen our understanding of the etiology of crime and psychopathology.
Subject(s)
Adrenal Hyperplasia, Congenital/psychology , Criminal Behavior/physiology , Polycystic Ovary Syndrome/psychology , Adult , Androgens/blood , Case-Control Studies , Cohort Studies , Female , Humans , Hyperandrogenism/psychology , Male , Middle Aged , Psychopathology , Sweden , Testosterone/blood , Young AdultABSTRACT
OBJECTIVE: The psychosocial implications of polycystic ovary syndrome (PCOS) phenotypes have been investigated in different patient populations, but little attention was paid to adolescent and young women. The aim of this study was to evaluate the psychosocial correlates of PCOS and other hyperandrogenic states in a population of late adolescent and young females and to provide a psychological characterization of specific clinical hyperandrogenic phenotypes. DESIGN: This was a cross-sectional study. PATIENTS: High school female students, aged 16-19 years. MEASUREMENTS: The study protocol was designed with three possible levels of participation characterized by an increased level of commitment. For the specific purposes of this investigation, we focused on the subsamples of students whose clinical state was assessed by medical examination (n = 835) and for whom additional laboratory tests were available (n = 394). Psychological evaluation encompassed psychological distress, levels of stress, well-being, illness behaviour and quality of life (as measured by the Symptom Questionnaire, the Psychosocial Index and the Psychological Well-Being scales). RESULTS: Significantly higher levels of psychological distress and impaired well-being and quality of life were found among late adolescent and young women with isolated clinical hyperandrogenism compared to their normal counterparts. Furthermore, females with PCOS showed significantly greater hostility/irritability compared to healthy control subjects. CONCLUSIONS: These findings highlight the importance of early recognizing and adequately managing psychological distress in such patients.
Subject(s)
Hyperandrogenism/psychology , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Male , Polycystic Ovary Syndrome/psychology , Quality of Life , Surveys and Questionnaires , Young AdultABSTRACT
OBJECTIVE: This study was conducted to explore the association between sexual orientations and polycystic ovary syndrome (PCOS)-related parameters. MATERIALS AND METHODS: A cross-sectional study with participants recruited from the regular outpatient clinic at the Department of Obstetrics and Gynecology at Taipei Medical University Hospital, Taipei, Taiwan between July 2012 and December 2013 was carried out. A total of 97 women met the criterion of having been diagnosed with PCOS. Among these 97 women, 89 were heterosexuals and eight were self-identified as lesbians. At the same time, 78 women without PCOS were enrolled to serve as the control group. Participants were given a standard questionnaire and had blood withdrawn for biochemical analysis of androgen parameters--including total testosterone, androstenedione, sex hormone binding globulin, free androgen index, 17ß-estradiol (E2), luteinizing hormone, and follicular-stimulating hormone. The biochemical data were measured to compare the PCOS clinical parameters present in people of different sexual orientations (lesbians and heterosexuals). RESULTS: The women with PCOS, regardless of sexual orientation, had higher percentages and serum levels of hyperandrogenism-related clinical parameters than the women without PCOS [acne (87.5% and 60.7% vs. 23.1%), p < 0.001]; hirsutism (62.5% and 57.3% vs. 15.4%, p ≤ 0.001)]; and biochemical parameters (total T, p < 0.05 or p < 0.001, and luteinizing hormone/follicular-stimulating hormone ratio, p ≤ 0.001]. The sexual orientation of women with PCOS affected their body mass index (BMI), because lesbians with PCOS possessed higher BMI than heterosexual women with PCOS (26.5 ± 1.9 vs. 22.5 ± 0.55; p < 0.05). However, hyperandrogenism-related clinical and biochemical parameters were not significantly different statistically between women with PCOS but of different sexual orientations. CONCLUSION: Our preliminary data showed that sexual orientation influenced the BMI of women with PCOS, but did not affect hyperandrogenism-related clinical or biochemical characteristics. This observation requires further confirmation.
Subject(s)
Heterosexuality/statistics & numerical data , Homosexuality, Female/statistics & numerical data , Polycystic Ovary Syndrome/psychology , Adult , Biomarkers/blood , Case-Control Studies , Cross-Sectional Studies , Female , Humans , Hyperandrogenism/blood , Hyperandrogenism/diagnosis , Hyperandrogenism/etiology , Hyperandrogenism/psychology , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/complications , Surveys and Questionnaires , TaiwanSubject(s)
Androgens/blood , Athletes , Hyperandrogenism , Sex Determination Analysis , Sports/ethics , Adolescent , Adult , Biomarkers/blood , Circumcision, Female/ethics , Delivery of Health Care/ethics , Ethics, Medical , Female , Gonads/surgery , Humans , Hyperandrogenism/diagnosis , Hyperandrogenism/psychology , Hyperandrogenism/therapy , Policy , Sex Determination Analysis/ethics , Young AdultABSTRACT
OBJECTIVE: Quality of life is impaired in polycystic ovary syndrome (PCOS). In this study, we compared the time to first prescription of antidepressants (ADM) in PCOS vs two control groups. DESIGN: Register-based cohort study. PATIENTS: One thousand and one hundred and twenty-four premenopausal women with hirsutism and/or PCOS, premenopausal women with hypertension (HT, n = 301), and age- and sex-matched population controls (controls, n = 4110). MEASUREMENTS: Prescriptions for ADM on secondary care contacts from regional registers. RESULTS: The median age at cohort entry in PCOS, HT and controls was 29, 34 and 29 years, respectively. Among PCOS, HT and controls, 227 (20%), 74 (25%) and 633 (15%), respectively, had prescriptions of ADM. The median time to first prescription of ADM in the PCOS, HT and control cohorts was 6·8, 6·6 and 7·2 years, respectively. The adjusted hazard ratio for time to prescription of ADM for HT vs PCOS was 1·36 [95% CI (1·02-1·82)], P = 0·039, and for controls vs PCOS, it was 0·75 [95% CI (0·64-0·88)], P < 0·001. Within patients with PCOS, hyperandrogenism contributed significantly to the model, likelihood ratio test P = 0·009. The adjusted hazard ratio for hyperandrogenism vs no hyperandrogenism was 1·97 (1·12-3·45), P = 0·018. CONCLUSION: Patients with PCOS had moderately but significantly decreased time to first prescription of ADM compared with age-matched healthy women, whereas patients with HT had the shortest time to prescription. In PCOS, prescription of ADM was associated with the presence of hyperandrogenism.
Subject(s)
Antidepressive Agents/therapeutic use , Hyperandrogenism/drug therapy , Polycystic Ovary Syndrome/drug therapy , Adolescent , Adult , Case-Control Studies , Cohort Studies , Denmark , Female , Humans , Hyperandrogenism/psychology , Middle Aged , Polycystic Ovary Syndrome/psychology , Proportional Hazards Models , Quality of Life , Research Design , Young AdultABSTRACT
OBJECTIVE: To determine association between health-related quality of life (HRQOL) and psychosexual variables in patients with polycystic ovary syndrome (PCOS). DESIGN: Cross-sectional study. SETTING: Two private gynecology clinics. PATIENT(S): A sample of 300 women with PCOS were entered into the study and were subdivided into three groups: hyperandrogenism (HA) and PCO morphology; menstrual dysfunction and PCO morphology; menstrual dysfunction and HA and/or PCO morphology. Then each patient completed the following questionnaires: the Hospital Anxiety and Depression Scale, the Body Image Concern Inventory, the Rosenberg Self-Esteem Scale, the Short-Form Health Survey, and the Female Sexual Function Index. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Both direct and indirect relationships among clinical symptoms, psychologic status, self-esteem, body image, and sexual function as independent predictors of HRQOL were examined with the use of structural equation modeling analysis. RESULT(S): The clinical variables and psychologic distress had the strongest indirect relationships with HRQOL in the HA phenotype. The highest effect of PCOS symptoms on HRQOL impairment in patients with menstrual irregularities along with HA and patients with menstrual irregularities along with polycystic ovaries was exerted by clinical variables, poor perception of self-worth, negative body image, and sexual dysfunction. CONCLUSION(S): In patients with various phenotypes of PCOS, the effects of mediating variables on HRQOL are different. In patients with PCOS, the findings suggest that mediating factors, especially psychologic distress, self-esteem, body image, and sexual function, play an important role and should be taken into consideration and adequately treated if present.
Subject(s)
Mental Health , Polycystic Ovary Syndrome/diagnosis , Quality of Life , Surveys and Questionnaires , Adult , Anxiety/diagnosis , Anxiety/psychology , Body Image , Chi-Square Distribution , Cross-Sectional Studies , Depression/diagnosis , Depression/psychology , Female , Humans , Hyperandrogenism/diagnosis , Hyperandrogenism/psychology , Iran , Menstrual Cycle , Menstruation Disturbances/diagnosis , Menstruation Disturbances/psychology , Phenotype , Polycystic Ovary Syndrome/physiopathology , Polycystic Ovary Syndrome/psychology , Predictive Value of Tests , Self Concept , Severity of Illness Index , Sexual Behavior , Young AdultABSTRACT
The role androgens play in female sexual desire remains unclear. We investigated whether androgen sensitivity or elevated androgen levels contributed to sexual desire using a motivational model of sexual desire. Eighty-five women diagnosed with polycystic ovary syndrome (PCOS) were categorized depending on whether they exhibited clinical symptoms of androgen sensitivity or high biochemical androgen levels. Additionally, instead of looking at desire as a uniform construct, we divided desire based on the reasons why women experienced desire, thus distinguishing desire to have sex for relational purposes from the desire to have sex for mating selection or physical pleasure. Findings confirmed that clinical signs suggesting sensitivity to androgen levels, but not biological levels of androgens per se predicted levels of sexual desire. Moreover, in agreement with our hypothesis, we found support for a relationship between androgen sensitivity and some, but not other aspects of sexual desire. Cues that are most closely related to mating selection were significantly associated with androgen sensitivity, but not cues associated with desiring sex to feel emotionally close or create a love bonding with a partner. This study presents a new way to investigate desire and shows some preliminary findings on the importance to consider androgen sensitivity when investigating the relationship between sexual desire and hormones.
Subject(s)
Androgens/blood , Hyperandrogenism/psychology , Libido/physiology , Polycystic Ovary Syndrome/psychology , Sexual Behavior/physiology , Adolescent , Adult , Female , Humans , Hyperandrogenism/blood , Polycystic Ovary Syndrome/blood , Sexual Behavior/psychologyABSTRACT
The parameters of female and male sexual behavior in 3- and 6- month old female rats which were exposed to an androgen excess (subcutaneous implantation of Silastic capsules containing 5 mg of crystalline testosterone) from the beginning of pubertal period (at the age of 35 days), or within postpubertal period (at the age of 4 months). Hyperandrogenia in pubertal period had no effect on female sexual behavior formation, but it led to appearance of male behavior components in 100% of animals. In female rats which were implanted with testosterone capsules in postpubertal period, sexual disturbances were more pronounced and were characterized by masculinization and defeminization, which was due to a higher degree of androgenic saturation. The data obtained suggest a leading role of hyperandrogenemia in the pathogenesis of sexual behavior disturbances in female rats in different periods of individual development.
Subject(s)
Androgens/pharmacology , Hyperandrogenism/psychology , Sexual Behavior, Animal/drug effects , Testosterone/pharmacology , Age Factors , Animals , Delayed-Action Preparations , Female , Hyperandrogenism/chemically induced , Rats , Rats, Wistar , Sexual Maturation/drug effectsABSTRACT
PURPOSE OF REVIEW: To review what is understood about the pathophysiology of polycystic ovarian syndrome (PCOS), the diagnostic challenges of PCOS in adolescent women, associated risk factors, as well as the best evidence-based treatment options for adolescence. RECENT FINDINGS: Diagnosing PCOS in adolescents requires a unique set of criteria for which no single marker currently exists. Adolescents at high risk for developing the syndrome are congenital virilization, low birth weight, premature pubarche, central precocious puberty, large for gestational age girls born to overweight mothers, obesity syndromes, insulin-resistant features, and girls born to parents with PCOS, central obesity, or diabetes in whom PCOS ought to be suspected when associated with irregular menses. Insulin, hyperandrogenemia, and adipocytokines are integral players in the pathophysiology of PCOS. PCOS may be an inheritable trait; however, no gene has yet been identified. Quality of life remains a concern for young women with PCOS. Lifestyle modifications geared to prevent long-term sequelae remain the first-line treatment in conjunction with oral contraceptive pills. SUMMARY: Identifying PCOS in adolescents remains a diagnostic dilemma, but early intervention and treatment can improve long-term health.
Subject(s)
Contraceptives, Oral, Hormonal/administration & dosage , Hyperandrogenism/diagnosis , Obesity/prevention & control , Polycystic Ovary Syndrome/diagnosis , Adolescent , Adolescent Health Services , Body Image/psychology , Contraceptives, Oral, Hormonal/pharmacology , Early Diagnosis , Female , Humans , Hyperandrogenism/drug therapy , Hyperandrogenism/psychology , Insulin Resistance , Menstruation Disturbances/etiology , Obesity/complications , Polycystic Ovary Syndrome/drug therapy , Polycystic Ovary Syndrome/psychology , Quality of Life , Risk Factors , Risk Reduction BehaviorABSTRACT
Effects of chronic stress (daily 30-min immobilization) on 35-45 days of life and its combination with androgenization (implantation of testosterone-containing capsules on 33rd day of life) on reproductive system of 2.5 month old female rats were studied. The term of sexual maturation, estrous cycles regularity and structure, blood plasma levels of testosterone, progesterone and androstenedione as well as ovarian histology were examined. Androgenization resulted in the blood plasma testosterone level increase and the androstenedione level decrease, development of oligo- or anovulatory condition characterized by disorders or discontinuation in estrous cyclicity. We also detected abrupt reduction or absence of postovulatory luteal bodies, cysts formation and ovarian interstitial tissue overgrowth. All experimental animals had normal blood plasma corticosterone level. Stressed rats had no considerable changes in reproductive system except of some cyclicity disorders. Stressed against androgenization rats demonstrated delayed pubescence, an increased number of ovarian cysts along with attenuation ofandrogenization-caused negative effects on the sexual cyclicity.
Subject(s)
Hyperandrogenism/pathology , Ovary/pathology , Sexual Maturation , Stress, Psychological/pathology , Androstenedione/blood , Animals , Chronic Disease , Corticosterone/blood , Disease Models, Animal , Estrous Cycle/physiology , Female , Hyperandrogenism/blood , Hyperandrogenism/physiopathology , Hyperandrogenism/psychology , Ovary/growth & development , Rats , Rats, Wistar , Sexual Maturation/physiology , Stress, Psychological/blood , Stress, Psychological/physiopathology , Stress, Psychological/psychology , Testosterone/bloodABSTRACT
BACKGROUND: Increased prevalence of psychological morbidities, including anxiety, depression and eating disorders, has been reported in women with polycystic ovary syndrome (PCOS) in comparison with normal ovulating, nonhyperandrogenemic women. AIM OF THE STUDY: To investigate the relationship between the degree of anxiety, depression and eating disorders via self-reported symptoms and the severity of hormonal and metabolic aberrations in women with PCOS. For this purpose, the PCOS cohort was subdivided into three subgroups according to the degree of anxiety. METHODS: One hundred and thirty women with PCOS of similar age and BMI were studied. In each subject, hormonal and metabolic status as well as psychological profile was assessed with the use of specific questionnaires. Specifically, anxiety (trait and state) was assessed with the use of STAI-T and STAI-S, while depression and eating disorders were evaluated with the use of the Beck Depression Inventory and the Eating Attitudes test, respectively. RESULTS: The subgroups did not differ in age and BMI. Subjects with the highest STAI-S compared with those with the lowest STAI-S displayed significantly higher the homeostasis assessment model-insulin resistance (HOMA-IR) and free androgen index values (P < 0·05), respectively. Regarding trait anxiety, assessed by STAI-T, HOMA-IR values were significantly elevated (P < 0·05) in the subgroup with the higher STAI-T score compared with the HOMA-IR in the group with the lower STAI-T score. CONCLUSIONS: In women with PCOS, the degree of anxiety, state and trait (STAI-S, STAI-T) appears to vary in a pattern similar to that of hyperandrogenemia and insulin resistance, independently of age and BMI. The pathophysiological mechanisms underlying the association of psychological morbidities with androgen excess and insulin resistance in PCOS remain to be elucidated.
Subject(s)
Anxiety/complications , Anxiety/physiopathology , Polycystic Ovary Syndrome/physiopathology , Polycystic Ovary Syndrome/psychology , Adolescent , Adult , Anxiety/metabolism , Body Mass Index , Female , Humans , Hyperandrogenism/etiology , Hyperandrogenism/metabolism , Hyperandrogenism/psychology , Insulin Resistance/physiology , Polycystic Ovary Syndrome/metabolism , Prospective Studies , Young AdultABSTRACT
OBJECTIVE: Very little is known about the mental health status in children with genetic causes of hyperandrogenism. This study sought to characterize psychiatric morbidity in this group. DESIGN/METHODS: Children (8-18 years) with the diagnosis of classic congenital adrenal hyperplasia (CAH) or familial male precocious puberty (FMPP) underwent a semi-structured psychiatric interview, the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version. According to sex and the literature, incidence of identified psychopathology was compared between the two endocrinological groups. We evaluated 72 patients: 54 CAH (21 females) and 18 FMPP. RESULTS: Twenty-four (44.4%) CAH patients and 10 (55.6%) FMPP patients met the criteria for at least one lifetime psychiatric diagnosis. Attention-deficit hyperactivity disorder (ADHD) was present in 18.2% of CAH males, 44.4% of FMPP males, and one case (4.8%) in CAH females. A high rate of anxiety disorders was also found in all the three groups (17-21%). Relative to females with CAH, the FMPP patients exhibited higher rates of ADHD. Age at diagnosis and the treatment modalities were not associated with psychopathology. Rates of psychiatric disorder, specifically ADHD and anxiety disorders, were higher than in the general population. CONCLUSION: Although anxiety disorders may occur at an increased rate in children with chronic illness, androgens may contribute to higher risk for psychopathology in pediatric patients with genetic cause of excess androgen. Early diagnosis and treatment of childhood hyperandrogenism is essential for optimal development. The results suggest that assessment for psychiatric disorders should be part of the routine evaluation of these patients.
Subject(s)
Hyperandrogenism/genetics , Hyperandrogenism/psychology , Mental Disorders/genetics , Mental Disorders/psychology , Adolescent , Adrenal Hyperplasia, Congenital/diagnosis , Adrenal Hyperplasia, Congenital/genetics , Adrenal Hyperplasia, Congenital/psychology , Anxiety/diagnosis , Anxiety/genetics , Anxiety/psychology , Attention Deficit Disorder with Hyperactivity/diagnosis , Attention Deficit Disorder with Hyperactivity/genetics , Attention Deficit Disorder with Hyperactivity/psychology , Child , Female , Humans , Hyperandrogenism/complications , Hyperandrogenism/diagnosis , Male , Mental Disorders/diagnosis , Puberty, Precocious/diagnosis , Puberty, Precocious/genetics , Puberty, Precocious/psychologyABSTRACT
BACKGROUND: The characteristics of polycystic ovary syndrome (PCOS) such as hyperandrogenism and anovulation can be highly stressful and might negatively affect psychological well-being and sexuality. The objective of this study was to evaluate the association between PCOS characteristics and psychological well-being as well as sexarche. METHODS: Patients (n = 1148) underwent standardized clinical evaluation. Psychological well-being was investigated in 480 patients with the Rosenberg self-esteem scale (RSES), the body cathexis scale (BCS) and the fear of negative appearance evaluation scale (FNAES). Sexarche was also assessed. RESULTS: Amenorrhoea was associated with lower self-esteem (P = 0.03), greater fear of negative appearance evaluation (P = 0.01) and earlier sexarche (P= 0.004). Hyperandrogenism and acne were associated with poorer body satisfaction (P = 0.03, 0.02, respectively). Hirsutism and BMI were negatively associated with all psychological variables (RSES, P = 0.01; BCS, P = 0.05; FNAES, P = 0.02 and RSES, P = 0.03; BCS, P = 0.001; FNAES, P = 0.03, respectively). CONCLUSIONS: Our results suggest that menstrual irregularities might be related to sexarche. Moreover, this study stresses that the treatment of women with PCOS should notably focus on physical but also on psychological and sexual characteristics.
Subject(s)
Coitus/psychology , Polycystic Ovary Syndrome/psychology , Self Concept , Stress, Psychological/psychology , Amenorrhea/complications , Amenorrhea/psychology , Body Image , Female , Humans , Hyperandrogenism/complications , Hyperandrogenism/psychology , Linear Models , Polycystic Ovary Syndrome/complications , Surveys and QuestionnairesABSTRACT
BACKGROUND: The etiology of polycystic ovary syndrome (PCOS) is poorly understood, as is the impact of female hyperandrogenism on psychosocial and psychosexual behavior. AIM: The present study sought to test whether women with PCOS self-report more masculine sex-typed behavior in childhood, at adolescence, and as adults. SUBJECTS AND METHODS: Sixty-one women (34 women self-reporting a clinical diagnosis of PCOS and 27 control women not reporting a PCOS diagnosis) completed a questionnaire containing items on childhood sex-typed behavior, adolescent behavior, and present masculinity, femininity and mood. RESULTS: Results revealed significant differences (p<0.05) in retrospective self-reports of childhood sex-typed behavior and gender conformity according to PCOS status, with women in the PCOS group reporting less feminine childhood behavior, and less gender-typical behavior. A composite of sex-typed behaviors did not differ according to PCOS status at adolescence, although several individual items did. As adults, we found no differences between the groups in masculinity and femininity, although PCOS women reported lower happiness than controls (p<0.05), and trends toward a bisexual orientation and having changed sex orientation more often than controls (p<0.10). CONCLUSION: Results of this pilot study provide evidence of PCOS women self-reporting discrete psychosocial developmental patterns compared to non-PCOS women. These differences in retrospective self-reported accounts may be factual or biased by current psychosocial differences, such as depression.
Subject(s)
Gender Identity , Polycystic Ovary Syndrome/psychology , Sexual Behavior , Adolescent , Adult , Affect/physiology , Age Factors , Child , Child, Preschool , Female , Humans , Hyperandrogenism/psychology , Pilot Projects , Retrospective Studies , Sex Characteristics , Young AdultABSTRACT
OBJECTIVE: The prevalence of DSM IV-defined eating disorders is evaluated in a population of women with facial hirsutism. METHOD: The Structured Clinical Interview (SCID) for the Diagnostic and Statistical Manual for Mental Disorders, fourth edition (DSM IV) and the Eating Disorder Evaluation (EDE) were administered to 80 hirsute women presenting routinely to an endocrine outpatient clinic. Objective phenotypic severity of hyperandrogenic symptoms, gender role, self-esteem, and social adjustment were quantified using validated measures and weight, height, and fertility were assessed during interview. RESULTS: The prevalence of eating disorders was 36.3% (22.5% EDNOS, 12.6% Bulimia Nervosa, 1.3% Anorexia Nervosa). Depression, anxiety, low self-esteem, and poor social adjustment were more common in participants suffering from an eating disorder, and co-morbidity of PCOS was universal in eating disordered cases. CONCLUSION: Our study demonstrates that hirsute women are at high risk of developing an eating disorder. Factors associated with eating disorders are examined and explanatory hypotheses are suggested for the possible underlying mechanisms in these women.
Subject(s)
Feeding and Eating Disorders/epidemiology , Hirsutism/epidemiology , Adolescent , Adult , Anorexia Nervosa/diagnosis , Anorexia Nervosa/epidemiology , Anorexia Nervosa/psychology , Bulimia Nervosa/diagnosis , Bulimia Nervosa/epidemiology , Bulimia Nervosa/psychology , Cohort Studies , Comorbidity , Cross-Sectional Studies , Feeding and Eating Disorders/diagnosis , Feeding and Eating Disorders/psychology , Female , Gender Identity , Hirsutism/diagnosis , Hirsutism/psychology , Humans , Hyperandrogenism/diagnosis , Hyperandrogenism/epidemiology , Hyperandrogenism/psychology , Polycystic Ovary Syndrome/diagnosis , Polycystic Ovary Syndrome/epidemiology , Polycystic Ovary Syndrome/psychology , Risk Factors , Self Concept , Social AdjustmentABSTRACT
UNLABELLED: We addressed the question of whether a combination of obesity and hyperandrogenicity has a more severe influence on psychosocial behaviours, as reflected by eating behaviour and body image, compared to obesity alone. AIM: To study eating behaviour and body image in age-, pubertal- and BMI-matched overweight adolescent girls with and without hyperandrogenicity, and to compare the data with those from a control group of normal weight girls. METHODS: Overweight adolescent girls in late puberty with (n=10) and without hyperandrogenicity (n=8) and a control group of normal weight girls (n=9) were studied. The Eating Disorder Inventory for children (EDI-C) questionnaire was used to obtain information on eating behaviours and psychological characteristics, and silhouettes were used to evaluate body image. RESULTS: The girls with overweight but without hyperandrogenicity showed more disturbed eating behaviour and more psychological problems than did the girls with both overweight and hyperandrogenicity as compared to the healthy controls. The overweight group also had more feelings of ineffectiveness than the hyperandrogenic group. Both the overweight and the hyperandrogenic girls estimated themselves as being significantly larger and their ideal shape as being significantly smaller than their current shape. However, all overweight girls considered their current shape to be significantly smaller than it was objectively. CONCLUSIONS: The girl with overweight alone seemed to have more disturbed eating behaviour and more psychological problems than girls with combined overweight and hyperandrogenicity. This could indicate that different therapeutic interventions might be needed in attempts to reduce weight in the two groups.